June 2025 CCSS S03: Biosimilar and Interchangeable Biological Products: An Overview of Scientific Concepts and Practical Resources
Presented by:
Sabiha Khan, MD
Medical Officer
Office of Therapeutic Biologics and Biosimilars
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Silver Spring, Md.
and
Sarah Ikenberry, MA
Associate Director for Stakeholder Outreach and Education
Office of Therapeutic Biologic and Biosimilars
U.S. Food and Drug Administration
Silver Spring, Md.